Cannabis Research Gets Senate Stamp of Approval

Hopefully the Senate being cool with some Cannabis research is a signal that they may be ready to establish Federal Legalization! 

The U.S. Senate just approved a bill on Tuesday that is going to allow scientific research at an increased level, and it will include CBD as well. The bill, which is titled the Cannabidiol and Marijuana Research Expansion Act (S. 2032) was a unanimous pass, and the excitement behind it is just as powerful. 

“Existing regulations make medical marijuana research difficult and have prevented us from understanding exactly how medical marijuana can be used safely and effectively to treat various conditions,” said Senator Dianne Feinstein. “Our bill streamlines the research process and paves the way for marijuana-derived medications that are FDA-approved to treat serious medical conditions, like intractable epilepsy, in a way that will keep consumers safe.”

According to High Times, “S. 2032 would expedite the approval process for researchers planning to study cannabis or its derivatives. The measure also includes provisions that would streamline the development of FDA-approved drugs made with marijuana or CBD by allowing accredited medical and osteopathic schools, practitioners, research institutions, and manufacturers with a Schedule I registration to produce marijuana for their research.”

Fingers crossed that their acceptance for more research may mean that they may be swaying for more acceptance across the board. To keep tabs on Federal Legalization, you can check back on ACRONYM ZINE or scan for real time info.



ACRONYM ZINE strives to bring you the newest in Music, Politics, Pop Culture, and more by hunting down stories that matter most to you and those around you. To continue supporting ACRONYM, please visit any of our sections, share stories on your social media accounts, and make sure to like/follow us on the following sites:

 Instagram |  TikTok  |  Facebook  |  Twitter  |  Ko-Fi  |  Twitch


Founded and operated under ACRONYM LLC. To learn more, visit



Share on facebook
Share on twitter
Share on pinterest
Share on linkedin

Post a Comment

Related Posts